PCV40 - BUDGET IMPACT ANALYSIS OF RIVAROXABAN IN THE SECONDARY PREVENTION OF ACUTE CORONARY SYNDROMES IN GREECE
Abstract
Authors
P. Stafylas M. Karaiskou D. Arzoumanidou N. Kolevris A. Kotsanis S. Chatzopoulos S. Stephens O. Schoeman J. Briere I. Kanakakis